[1]
L. Endrenyi and L. Tothfalusi, “Do Regulatory Bioequivalence Requirements Adequately Reflect the Therapeutic Equivalence of Modified-Release Drug Products?”,
J Pharm Pharm Sci
, vol. 13, no. 1, pp. 107–113, May 2010.